Patients' views on cost effectiveness of drugs are important
Pollock, K.; Grime, J.
Bmj 321(7271): 1292
2000
ISSN/ISBN: 0959-8138 PMID: 11185766 Document Number: 520863
Document emailed within 1 workday
Related Documents
Lopert, R.; Lang, D.L.; Hill, S.R.; Henry, D.A. 2002: Differential pricing of drugs: a role for cost-effectiveness analysis? Lancet 359(9323): 2105-2107MacDonald, R. 2000: Cost effectiveness of multiple sclerosis drugs remains unknown Bmj 321(7258): 399
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Splett, P.L. 1991: Phase I: status report of existing data on the effectiveness, cost, and cost effectiveness of nutrition care services Journal of the American Dietetic Association Suppl: S9-14
Messori, A.; Trippoli, S.; Vaiani, M. 2002: Efficacy, safety, and cost of new anticancer drugs. Price needs to be evaluated against effectiveness Bmj 325(7375): 1302; Author Reply 1302
Hawkes, N. 2014: NICE uses wrong comparator to assess cost effectiveness of new drugs, report says Bmj 348: G2134
Boelaert, M.; Le Ray, D.; Van Der Stuyft, P. 2002: How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis Tropical Medicine and International Health: Tm and Ih 7(11): 955-959
Hoomans, T.; van der Roer, N.; Severens, J.L.; Delwel, G.O. 2010: Cost-effectiveness of new drugs impacts reimbursement decision making but room for improvement Nederlands Tijdschrift Voor Geneeskunde 154: A958
Schulman, K.A.; Kinosian, B.; Jacobson, T.A.; Glick, H.; Willian, M.K.; Koffer, H.; Eisenberg, J.M. 1990: Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management JAMA 264(23): 3025-3033
Pope, J.E.; Prashker, M.; Anderson, J. 2004: The efficacy and cost effectiveness of N of 1 studies with diclofenac compared to standard treatment with nonsteroidal antiinflammatory drugs in osteoarthritis Journal of Rheumatology 31(1): 140-149
Fatti, G.; Ngorima-Mabhena, N.; Chirowa, F.; Chirwa, B.; Takarinda, K.; Tafuma, T.A.; Mahachi, N.; Chikodzore, R.; Nyadundu, S.; Ajayi, C.A.; Mutasa-Apollo, T.; Mugurungi, O.; Mothibi, E.; Hoffman, R.M.; Grimwood, A. 2018: The effectiveness and cost-effectiveness of 3- vs. 6-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART-refill groups in Zimbabwe: study protocol for a pragmatic, cluster-randomized trial Trials 19(1): 79
Shade, S.B.; Kevany, S.; Onono, M.; Ochieng, G.; Steinfeld, R.L.; Grossman, D.; Newmann, S.J.; Blat, C.; Bukusi, E.A.; Cohen, C.R. 2013: Cost, cost-efficiency and cost-effectiveness of integrated family planning and HIV services Aids 27(Suppl 1): S87-S92
Namazi, M.R. 2004: Prescribing antidepressant drugs for pemphigus patients: An important point to keep in mind Dermatology Online Journal 10(1): 22
Mozes, B.; Confino-Cohen, R.; Halkin, H. 1988: Cost-effectiveness of in-hospital evaluation of patients with syncope Israel Journal of Medical Sciences 24(6): 302-306
Kahn, J.G.; Jiwani, A.; Gomez, G.B.; Hawkes, S.J.; Chesson, H.W.; Broutet, N.; Kamb, M.L.; Newman, L.M. 2014: The cost and cost-effectiveness of scaling up screening and treatment of syphilis in pregnancy: a model PLOS one 9(1): E87510
Mielck, A. 1988: Cost-effectiveness and cost-benefit approaches in programs designed to prevent AIDS Aids and Public Policy Journal 3(3): 19-22
Hudecková, H.; Straka, S.; Szilágyiová, M.; Avdicová, M.; Rusnáková, S. 2002: Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic Central European Journal of Public Health 10(4): 146-148
Deirdre Wulf 1981: Cost-Benefit and Cost-Effectiveness Analysis for Family Planning Programs International Family Planning Perspectives 7(4): 141-144
Drummond, M.F. 1985: Survey of cost-effectiveness and cost-benefit analyses in industrialized countries World Health Statistics Quarterly. Rapport Trimestriel de Statistiques Sanitaires Mondiales 38(4): 383-401
Walker, D. 2003: Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base? Health Policy and Planning 18(1): 4-17